LifeStance Health (LFST) Equity Average (2020 - 2026)

LifeStance Health has disclosed Equity Average across 7 years of filings, most recently posting $1.5 billion for Q1 2026.

• In Q1 2026, Equity Average rose 3.27% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 3.27% YoY), while the FY2025 annual figure was $1.5 billion, up 3.2% from the prior year.
• Equity Average retreated to $1.5 billion in Q1 2026, from $1.5 billion in the prior quarter.
• Over the last five years, Equity Average for LFST reached as high as $1.5 billion in Q1 2022 and fell as low as $1.4 billion in Q1 2024.
• The 5-year median for Equity Average is $1.5 billion (2025), against an average of $1.5 billion.
• Annual changes were most pronounced in 2022 — Equity Average surged 58.19% — and 2024, when it retreated 5.49%.
• A 5-year view of Equity Average shows it stood at $1.5 billion in 2022, then retreated by 5.45% to $1.4 billion in 2023, then decreased by 0.02% to $1.4 billion in 2024, then increased by 4.52% to $1.5 billion in 2025, then fell by 0.51% to $1.5 billion in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $1.5 billion, $1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.